Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2002:80:71-114.
doi: 10.1016/s0065-2776(02)80013-x.

Proteolysis and antigen presentation by MHC class II molecules

Affiliations
Review

Proteolysis and antigen presentation by MHC class II molecules

Paula Wolf Bryant et al. Adv Immunol. 2002.

Abstract

Proteolysis is the primary mechanism used by all cells not only to dispose of unwanted proteins but also to regulate protein function and maintain cellular homeostasis. Proteases that reside in the endocytic pathway are the principal actors of terminal protein degradation. The proteases contained in the endocytic pathway are classified into four major groups based on the active-site amino acid used by the enzyme to hydrolyze amide bonds of proteins: cysteine, aspartyl, serine, and metalloproteases. The presentation of peptide antigens by major histocompatibility complex (MHC) class II molecules is strictly dependent on the action of proteases. Class II molecules scour the endocytic pathway for antigenic peptides to bind and present at the cell surface for recognition by CD4+ T cells. The specialized cell types that support antigen presentation by class II molecules are commonly referred to as professional antigen presenting cells (APCs), which include bone marrow-derived B lymphocytes, dendritic cells (DCs), and macrophages. In addition, the expression of certain endocytic proteases is regulated either at the level of gene transcription or enzyme maturation and their activity is controlled by the presence of endogenous protease inhibitors.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Alfonso C, Karlsson L. Nonclassical MHC class II molecules. Annu. Rev. Immunol. 2000;18:113–142. - PubMed
    1. Alvarez-Fernandez M, Barrett A.J, Gerhartz B, Dando P.M, Ni J, Abrahamson M. Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site. J. Biol. Chem. 1999;274:19195–19203. - PubMed
    1. Amigorena S, Bonnerot C. Fc receptor signaling and trafficking: A connection for antigen processing. Immunol. Rev. 1999;172:279–284. - PubMed
    1. Amigorena S, Bonnerot C. Fc receptors for IgG and antigen presentation on MHC class I and class II molecules.Semin. Semin. Immunol. 1999;11:385–390. - PubMed
    1. Amigorena S, Webster P, Drake J, Newcomb J, Cresswell P, Mellman I. Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles. J. Exp. Med. 1995;181:1729–1741. - PMC - PubMed

MeSH terms